Novel parameter based on lipid indicators ratio improves prognostic value of plasma lipid levels in resectable colorectal cancer patients

doi:10.4240/wjgs.v13.i7.689

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 7

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4168)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-5) series.

Item

Count

PDF

216

WORD

123

HTML

2011

Figures (1-2)

194

Tables (1-5)

206

Sum=2750

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

445

Download

973

Sum=1418

Jul 27, 2021 (publication date) through Apr 28, 2024

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Surgery

ISSN

1948-9366

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastrointest Surg. Jul 27, 2021; 13(7): 689-701
Published online Jul 27, 2021. doi: 10.4240/wjgs.v13.i7.689

Table 5 Association between lipoprotein-cholesterol-apolipoprotein score with overall survival and progression-free survival in patients with colorectal cancer among different subgroups

		LA score
		PFS			OS
		n	Progression	HR (95%CI)	n	Death	HR (95%CI)
Age (yr)	< 65	330	90	0.725 (0.532-0.987)	330	49	0.626 (0.424-0.924)
Age (yr)	≥ 65	191	58	0.540 (0.358-0.814)	191	38	0.724 (0.437-1.199)
Sex	Male	321	97	0.671 (0.500-0.901)	321	58	0.756 (0.520-1.101)
Sex	Female	200	51	0.592 (0.366-0.956)	200	29	0.572 (0.333-0.981)
TNM stage	I/II	243	35	0.805 (0.421-1.538)	243	15	0.678 (0.265-1.735)
TNM stage	III/IV	278	113	0.632 (0.485-0.824)	278	72	0.676 (0.490-0.932)
Tumor location	Colon	320	91	0.793 (0.557-1.128)	320	53	0.686 (0.454-1.036)
Tumor location	Rectum	201	57	0.582 (0.411-0.826)	201	34	0.710 (0.450-1.121)
Tumor size (cm)	d < 2	12	2	0	12	2	0
	2 ≤ d < 5	374	108	0.575 (0.435-0.761)	374	61	0.636 (0.445-0.908)
	d ≥ 5	135	38	0.792 (0.485-1.294)	135	24	0.634 (0.354-1.137)
Differentiation	Low	56	18	0.504 (0.286-0.890)	56	11	0.298 (0.149-0.594)
	Medium	415	118	0.722 (0.534-0.977)	415	68	0.781 (0.528-1.155)
	High	50	12	0.534 (0.261-1.093)	50	8	0.704 (0.313-1.586)

LA: Lipoprotein cholesterol-apolipoprotein; PFS: Progression-free survival; OS: Overall survival; HR: Hazard Ratio; CI: Confidence interval.

Citation: Gu JN, Yao S, Cao YH, Deng SH, Mao FW, Jiang HY, He YT, Li XY, Ke SQ, Li HL, Li H, Liu XH, Liu HL, Wang JL, Wu K, Liu L, Cai KL. Novel parameter based on lipid indicators ratio improves prognostic value of plasma lipid levels in resectable colorectal cancer patients. World J Gastrointest Surg 2021; 13(7): 689-701
URL: https://www.wjgnet.com/1948-9366/full/v13/i7/689.htm
DOI: https://dx.doi.org/10.4240/wjgs.v13.i7.689